To randomly compare MiniArc and Monarc for:* efficacy as surgical correction of stress-incontinence* post-operative pain* complications* morbidity and post-operative recovery* the need for repeated stress-incontinence surgery or specialized…
ID
Source
Brief title
Condition
- Obstetric and gynaecological therapeutic procedures
Synonym
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
1. efficacy as surgical correction of stress urinary incontinence.
2. post-operative pain.
Secondary outcome
3. complications.
4. morbidity and post-operative recovery.
5. the need for repeated stress-incontinence surgery or specialized
physiotherapy.
6. pelvic floor function.
7. cost-effectiveness from a societal perspective.
Background summary
Stress urinary incontinence (SUI) is a worldwide common problem, especially
suffering women. In the past many operative techniques are developed to treat
stress urinary incontinence. One of the most successful techniques is the
TVT-procedure (tension free vaginal tape). Since its introduction, more than
1,000,000 procedures with TVT have been performed worldwide. A recent Cochrane
review concluded that the cure rates after TVT placement were similar to those
after open abdominal retropubic suspension with a low complication rate.
Initially suburethral tapes followed a retropubic route during insertion.
Later, the trans-obturator route was developed. One of the most used
transobturator slings is the Monarc. It has been shown that the trans-obturator
route is associated with a lower risk on post-operative bladder retention and
overactive bladder symptoms. Furthermore, the trans-obturator route is safer
as, during this procedure, it is almost impossible to perforate the bladder.
However, trans-obturator slings also carry some risk on morbidity of which
muscle pain (due to perforation of the obturator muscles) and bleeding (due to
perforation of the obturator vessels) are the most important. With the
intention to reduce the invasiveness of the retropubic and trans-obturator
approach, the MiniArc was developed.
Study objective
To randomly compare MiniArc and Monarc for:
* efficacy as surgical correction of stress-incontinence
* post-operative pain
* complications
* morbidity and post-operative recovery
* the need for repeated stress-incontinence surgery or specialized physiotherapy
* pelvic floor function
* cost-effectiveness from a societal perspective
Study design
Prospective multi-national randomised controlled trial.
Intervention
Surgical correction of symptomatic stress-incontinence with mini-sling
(MiniArc) or trans-obturator sling (Monarc) .
Study burden and risks
Burden: Before operation, 4 weeks and 12 months after operation, patients are
asked to fill in a validated questionnaire concerning pelvic floor problems and
general functioning. Also they have to complete a diary during the first 4
weeks after operation, concerning pain, use of analgetics and activities of
daily life. 6 Months after operation an interview by telephone will take place
to complete a short questionnaire (15 min). All questionnaires together takes
approximatively 2 hours spread over 12 months.
Risk: Both operative techniques (MiniArc and Monarc) are well accepted
procedures to treat stress urinary incontinence in women. In many centres these
procedures are commonly used. Therefore no extra risks are connected with
inclusion in the trial.
Meibergdreef 9
1105 AZ Amsterdam
NL
Meibergdreef 9
1105 AZ Amsterdam
NL
Listed location countries
Age
Inclusion criteria
Female symptomatic stress urinary incontinence resulting from urethral hypermobility and/or ISD (intrinsic sphincter deficiency).
Exclusion criteria
1. Subjects who have stage 2 or more genital prolaps, according to the ICS-classification
2. Subjects who undergo surgery for recurrence of stress incontinence
3. Subjects who undergo concomitant surgical procedures
4. Subjects who are pregnant or want to become pregnant
5. Subjects are not capable of giving informed consent
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
In other registers
Register | ID |
---|---|
CCMO | NL28973.018.09 |
OMON | NL-OMON29267 |